An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leuprolide Acetate 45 mg for Injectable Suspension Controlled Release in Subjects With Central (Gonadotropin-Dependent) Precocious Puberty—Part A and B
Latest Information Update: 05 Jul 2016
At a glance
- Drugs Leuprorelin (Primary)
- Indications Precocious puberty
- Focus Therapeutic Use
- 05 Jul 2016 New trial record